🔎 Trials Near Me

Dachaigh › Aillse Sgamhain Neo-chealla-beag › Kansas › Overland Park

Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Overland Park, KS

Tha 16 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Overland Park (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

A’ fastadhÌre 3
  • Research Site, Leawood · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06868277

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A’ fastadhÌre 2
  • University of Kansas Cancer Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06667076

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

A’ fastadhÌre 3
  • Saint Luke's South Hospital, Overland Park
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06758401

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

A’ fastadhÌre 2/3
  • MidAmerica Cancer Care - Research, Merriam · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04613596

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

A’ fastadhÌre 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06500481

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A’ fastadhÌre 1
  • The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
  • The University of Kansas Cancer Center, Investigational Drug Services, Fairway · 3 mìle air falbh
  • The University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04389632

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2/3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mìle air falbh
18 Minutes · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06031688

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

A’ fastadhÌre 1/2
  • The University of Kansas Cancer Center, Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT06244771

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

A’ fastadhSgrùdadh amharc
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

A’ fastadhÌre 1/2
  • The University of Kansas Cancer Center (KUCC), Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT04467723

A Study of IBI363 in Subjects with Advanced Solid Malignancies

A’ fastadhÌre 2
  • University of Kansas Medical Center (KUMC), Fairway · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Dùbh 2024 · NCT06281678

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

A’ fastadhSgrùdadh amharc
  • The University of Kansas Cancer Center (KUCC), Fairway · 3 mìle air falbh
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 23 Gearr 2024 · NCT05332925

Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile

Sgrùdaidhean eile ann an Overland Park

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.